Vitamin D has been marketed primarily as a bone health nutrient for decades. That framing undersells it considerably.
Vitamin D is technically a steroid hormone, one of the most potent gene regulators in the human body. It interacts with vitamin D receptors (VDRs) distributed throughout virtually every tissue, including dense populations in the brain: in the prefrontal cortex, hippocampus, cingulate gyrus, and thalamus. Areas that handle cognition, memory, mood, and attention.
Its insufficiency is also extremely common. Estimates consistently suggest that over 40% of adults in developed countries have blood levels below the threshold generally considered optimal for health, with higher rates among people who spend little time outdoors, live at northern latitudes, have darker skin, or are older adults.
The convergence of widespread deficiency and significant neurological presence makes vitamin D one of the most important nutritional conversations in brain health research today.
What Vitamin D Does in the Brain
Neuroprotection and Neurotrophic Support
Vitamin D regulates the expression of genes involved in neuroprotection, including those encoding neurotrophic factors like NGF (nerve growth factor) and GDNF (glial cell line-derived neurotrophic factor). These proteins support the survival, growth, and maintenance of neurons.
It also regulates genes involved in the clearance of amyloid precursor proteins, proteins associated with neurodegenerative disease when they accumulate. Whether vitamin D’s effect on these pathways translates to meaningful dementia risk reduction in humans is an active area of research, but the mechanistic basis for interest is well-founded.
Neurotransmitter Synthesis
Vitamin D is involved in the synthesis of serotonin and dopamine. Specifically, it activates the gene encoding tryptophan hydroxylase 2 (TPH2), the enzyme that converts tryptophan to serotonin in the brain. It also influences the expression of dopamine-converting enzymes.
This provides a mechanistic basis for the observed associations between low vitamin D status and depression. The relationship is bidirectional in research: people with depression have lower vitamin D levels on average, and supplementation trials in deficient individuals have found mood improvements compared to placebo, though effects in those already replete are smaller.
Inflammation Regulation
Vitamin D is a potent modulator of immune function and inflammation. It suppresses pro-inflammatory cytokine production and promotes anti-inflammatory signalling. In the brain, where neuroinflammation is increasingly recognised as a driver of cognitive decline, depression, and neurodegeneration, this immune-regulatory role has significant implications.
Several studies have found associations between low vitamin D and elevated inflammatory markers in the brain, including microglial activation, the brain’s resident immune cells. Chronic microglial activation is a feature of several neurodegenerative conditions.
The Research on Vitamin D and Cognition
Observational Evidence
The observational literature is consistent. Multiple large prospective studies have found that lower vitamin D status is associated with faster rates of cognitive decline over time and higher risk of dementia. A 2014 study in Neurology following over 1,600 adults for six years found that those severely deficient in vitamin D had more than double the risk of developing Alzheimer’s disease and all-cause dementia compared to those with sufficient levels.
Cross-sectional studies consistently find associations between vitamin D levels and performance on tests of memory, executive function, and processing speed, with effects most pronounced at the lower end of the vitamin D spectrum.
Interventional Evidence
Randomised trials have produced more variable results, a pattern familiar from other nutritional interventions. Effects are most consistently observed in people with low baseline levels; supplementing those already replete produces smaller or no measurable changes.
A meta-analysis published in Nutrients in 2020 examining vitamin D supplementation and cognitive outcomes found positive effects particularly in older adults and those with baseline deficiency, with improvements in attention and processing speed among the most consistent findings.
Why Deficiency Is So Common
The Sunlight Problem
The primary source of vitamin D is synthesis in the skin upon exposure to UVB radiation. This synthesis is affected by latitude, season, time of day, skin pigmentation, age, sunscreen use, and time spent outdoors. In many northern countries, UVB levels are insufficient for vitamin D synthesis for up to six months of the year.
Melanin, the pigment giving skin its darker colour, reduces UVB absorption, meaning people with darker skin require significantly more sun exposure to produce the same amount of vitamin D. This is one reason deficiency rates are substantially higher in darker-skinned populations living at northern latitudes.
Age-Related Decline
The skin’s capacity to synthesise vitamin D decreases with age, by approximately 75% between the ages of 20 and 70. Older adults also tend to spend less time outdoors and may have reduced dietary intake. For this population, sun exposure as a primary vitamin D strategy becomes increasingly unreliable.
Food Sources and Supplementation
Dietary vitamin D is found in fatty fish (salmon, mackerel, sardines), egg yolks, and fortified foods. But dietary sources alone are rarely sufficient to maintain optimal blood levels, the amounts in food are simply too small relative to the body’s requirements.
The form in supplements matters. Vitamin D3 (cholecalciferol, the form produced by skin) raises blood levels more effectively than D2 (ergocalciferol). The active form in the body is 1,25-dihydroxyvitamin D (calcitriol), but supplements correctly use D3 as the precursor since calcitriol’s short half-life makes it impractical.
Vitamin D is fat-soluble, absorption is significantly improved when taken with a meal containing fat. Taking it with the largest meal of the day is a simple and meaningful practical step.
Blood testing (25-hydroxyvitamin D) is the appropriate way to assess status. General guidance places optimal levels at 50-80 nmol/L (20-32 ng/mL), though some researchers argue for higher targets. Without testing, supplementation at 1,000-2,000 IU daily is widely considered a reasonable maintenance dose for adults in low-sunlight environments, but individual requirements vary considerably.
This article is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before beginning any supplement protocol.